GlassScriptPhysician profile
Paul Sapia
NPI 1780067017
$18,686.14
in general payments reported to CMS, 2019-2025
20 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $203 · 2021: $1,039 · 2022: $1,436 · 2023: $1,567 · 2024: $1,346 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Food and Beverage: $5,719 · Travel and Lodging: $4,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Food and Beverage | $5,718.77 |
| Travel and Lodging | $4,290.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $12,244.17 | 2021-2025 | Indigo System |
| Boston Scientific Corporation | $1,932.34 | 2021-2025 | Rotapro, Stingray, Avvigo Guidance System |
| Medtronic, INC. | $1,303.94 | 2021-2025 | Symplicity G3, Onyx Frontier, Corevalve Evolut R |
| Amgen INC. | $610.69 | 2020-2025 | Repatha, Repatha |
| Inari Medical, INC. | $480.40 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $431.65 | 2020-2025 | Eliquis, Camzyos |
| Shockwave Medical, INC | $238.84 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $221.93 | 2020-2025 | Farxiga |
| Cardiovascular Systems INC. | $177.90 | 2021 | |
| Abbott Laboratories | $174.84 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit, Perclose Proglide |
| Abiomed | $171.16 | 2025 | |
| Novo Nordisk INC | $167.73 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Recor Medical INC | $138.91 | 2025 | Paradise Ultrasound Renal Denervation System |
| Philips North America LLC | $119.40 | 2023 | |
| Pfizer INC. | $104.27 | 2020-2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $56.56 | 2024-2025 | |
| Lantheus Medical Imaging, INC. | $40.66 | 2021 | |
| Esperion Therapeutics, INC. | $37.38 | 2024-2025 | Nexletol |
| Chiesi USA, INC. | $20.36 | 2021 | |
| Siemens Medical Solutions USA, INC. | $13.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Sapia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.